Alteplase (TPA) for Clotted Dialysis Catheters

Hathiwala, S C; Hristea, I.; Khalili, Vahid

doi:10.1177/039139880002301002

Int J Artif Organs

2000

DOI: 10.1177/039139880002301002

|View full text |Cite

Alteplase (TPA) for Clotted Dialysis Catheters

S C Hathiwala

I. Hristea

Vahid Khalili

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2011

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thrombolysis with alteplase (recombinant tissue‐type plasminogen activator [t‐PA]) has been successfully used in clotted CVC and AV grafts in various regimens and techniques, such as pulse‐spray thrombolysis or lyse‐and‐wait or as a complementary treatment to invasive procedures, that is, angioplasty (4–6). However, there are limited data regarding the use of t‐PA in the treatment of occluded AV fistulas (7,8).…”

mentioning

confidence: 99%

Thrombolysis With Alteplase: A Non-Invasive Treatment for Occluded Arteriovenous Fistulas and Grafts

et al. 2011

View full text Add to dashboard Cite

Thrombolysis with recombinant tissue type plasminogen activator (t-PA) has been successfully used in occluded arteriovenous (AV) hemodialysis grafts and tunneled catheters, especially as an adjunctive regimen to invasive or semi-invasive procedures. We performed a retrospective study to evaluate the effectiveness and outcomes of thrombolysis with t-PA in occluded AV hemodialysis accesses. We used low doses of t-PA in 40 cases of thrombosed AV fistulas and grafts. Primary success was noted in 55% of the cases ensuring patency rates of 30 and 90 days at 90.9 and 69.8%, respectively. Inflammation (increased C-reactive protein concentration) and shorter functioning time of AV access were independently associated with primary outcome, whereas there was no difference in outcome between AV fistulas or grafts. No major complications were noted. We conclude that the use of t-PA is a safe and easy treatment for clotted AV accesses that can be applied in an outpatient setting.

show abstract

mentioning

confidence: 99%

Thrombolysis With Alteplase: A Non-Invasive Treatment for Occluded Arteriovenous Fistulas and Grafts

et al. 2011

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Alteplase (TPA) for Clotted Dialysis Catheters

Cited by 1 publication

References 8 publications

Thrombolysis With Alteplase: A Non-Invasive Treatment for Occluded Arteriovenous Fistulas and Grafts

Thrombolysis With Alteplase: A Non-Invasive Treatment for Occluded Arteriovenous Fistulas and Grafts

Contact Info

Product

Resources

About